NCT06128980View on ClinicalTrials.gov

Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

348

Participants

Timeline

Start Date

January 9, 2025

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2032

Conditions
Heart Failure With Reduced Ejection FractionHeart Rhythm Disorder
Interventions
DRUG

GDMT

Sequential weaning starting with SGLT2i - MRA - BB - ACEi/ARB/ARNi

Trial Locations (1)

2730

RECRUITING

Herlev-Gentofte Hospital, Copenhagen

All Listed Sponsors
collaborator

Nordsjaellands Hospital

OTHER

collaborator

University Hospital Bispebjerg and Frederiksberg

OTHER

collaborator

Zealand University Hospital

OTHER

collaborator

Copenhagen University Hospital, Hvidovre

OTHER

lead

Herlev and Gentofte Hospital

OTHER